Table 2.
Tissue | Intervention/Observation | Effect/Comment | Reference(s) |
---|---|---|---|
Bone and Cartilage | OE of ATF6 in foetal mouse metatarsals ex vivo as well as C3H10T1/2 and ATDC5 cells in vitro | Enhanced chondrocyte hypertrophy, mineralisation, and endochondral bone growth in metatarsals and enhanced chondrocyte differentiation in vitro | [17–19] |
KD of ATF6 in C3H10T1/2 and ATDC5 cells (adenoviral siRNA delivery system) | KD➔Inhibition of chondrocyte differentiation and hypertrophy | ||
KD of ATF6α in murine bone marrow stromal cells and C3H10T1/2 cells | BMP2➔RunX2➔ATF6➔osteocalcin | ||
MC3T3-E1 + MTA ATF6 KD in MTA-treated cells |
MTA stimulated osteoblastic differentiation via upregulation of osteocalcin ATF6 KD abrogated MTA-induced mineralisation |
[20] | |
OE of ATF6 in human dental pulp cells | Matrix mineralisation and odontoblastic differentiation increased | [21] | |
Ocular Tissue | Immunofluorescent staining of ATF6 expression in the embryonic eye lens (FVB/N-Har mice) | ATF6 expression and cleavage were detected in lens fibre cells in the developing mouse embryo | [24] |
Homozygosity mapping, linkage analyses and exome sequencing in patients with achromatopsia (ACHM) | Patients with ACHM displayed ATF6 mutations, which severely compromise ATF6 function. Patients also exhibited foveal deficits, suggesting that ATF6 plays a crucial role in the development of the fovea and cone photoreceptors in humans | [25–27] | |
Early-onset photoreceptor degeneration | ATF6 splice-variant mutations causing compromised photoreceptor function | ||
Nervous tissue | Western blot analyses of glycosylated ATF6 expression in adult and embryonic mouse brains | Compared to adult tissue, the expression of partially glycosylated ATF6 is elevated in the brains of mouse embryos | [30] |
Olfactory sensory neurons | Low-level expression (relative to ATF5) of ATF6 during development | [32] | |
Immunohistochemical staining of ATF6 (cytoplasmic and nuclear) in the developing rat cerebellum | ATF6 was activated at postnatal day 7 (prior to the appearance of myelin), with maximal nuclear-localised ATF6 visualised at postnatal day 10 (onset of myelination) | [33] | |
Muscle | OE of active ATF6 in myoblasts | ↑ ATF6 ➔ ↓ Mcl-1 ➔ apoptotic myoblast cells. ATF6 may regulate muscle cell development through promoting post-translational modification of Mcl-1 |
[35] |
OE of DKK3 in mESCs Transient ATF6 overexpression or siRNA-mediated ATF6 KD at day 2 of ESC differentiation |
DKK3 induced differentiation of ESCs into smooth muscle cells (SMCs) ↑ ATF6 during DKK3-induced ESC-SMC differentiation OE and KD ➔ ATF6 is involved in DKK3-mediated SMC generation via ↑myocardin expression |
[36] | |
Ovarian Tissue | Analyses of ATF6 and associated markers during the bovine corpus luteum lifespan and in goat granulosa | ATF6 and ATF4➔ ↑CHOP and ↑caspase-12 | [37–39] |
Molecular and immunohistochemical detection of ATF6α during peri-implantation and the oestrous cycle in mice | ↑ATF6α mRNA and protein in the d5 uterus close to the implantation site and in d7–8 secondary decidual zone; ATF6α expression affected by progesterone and estrogen in ovariectomised mice | [40] | |
Adipose Tissue | KD of ATF6α in C3H10T1/2 cells | ATF6α KD ➔ ↓ C3H10T1/2 differentiation and ↓ lipid accumulation | [41] |
Glucose deprivation | ↓SREBP2-mediated lipogenesis | [42] | |
Adipogenesis in salmon and rainbow trout | ATF6/ATF6β upregulated during adipogenesis | [14, 43] | |
OE and KD in pre-adipocytic 3 T3-L1 cells | ATF6 OE ➔ ↑TIS7 in 3T3-L1 cells ATF6KD under hypoxia➔↑AP-2 in pre-adipocytes; ATF6 KD ↓ hypoxia-induced ↑TIS7 and ↓adipogenic gene expression |
[44] | |
Early Stem Cell/Mesoderm | Small molecule ATF6 activation in human ESCs | ATF6 activation suppressed pluripotency, enhanced stem cell differentiation and steered cells towards mesodermal fate | [28] |
Key: ACHM achromatopsia, ATF6 activating transcription factor 6, CHOP C/EBP homologous protein, ESC embryonic stem cell, KD knockdown, KO knockout, MCL-1 myeloid cell leukaemia sequence 1, MTA mineral trioxide aggregate, OE over-expression, PCR polymerase chain reaction, RunX2 runt-related transcription factor 2, SMC smooth muscle cell, SREBP-2 sterol regulatory element binding protein 2, TIS7 tetradecanoyl phorbol acetate induced sequence 7